ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2018-12-14
What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2018-12-14 (fiscal Q1 2019): 30 published measures, 61 facts as tagged in accession 0001493152-18-017545.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-12-14
- Fiscal period
- fiscal Q1 2019
- Accession
- 0001493152-18-017545 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 32,177,108 | USD | |
| At 2018-07-31 | 30,246,472 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 6,979,387 | USD | |
| At 2018-07-31 | 7,322,266 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 25,197,721 | USD | |
| At 2018-07-31 | 22,924,206 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 19,016,067 | USD | |
| At 2018-07-31 | 3,803,627 | USD | |
| At 2017-10-31 | 14,661,418 | USD | |
| At 2017-07-31 | 11,444,676 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | -7,575,615 | USD | 92 |
| 2017-08-01 to 2017-10-31 | -5,900,452 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | -6,778,187 | USD | 92 |
| 2017-08-01 to 2017-10-31 | -5,079,862 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 8,287,514 | USD | 92 |
| 2017-08-01 to 2017-10-31 | 8,303,348 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 13,731,794 | USD | 92 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | -141,656,436 | USD | |
| At 2018-07-31 | -134,080,821 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 2,435 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 1,204,791 | USD | |
| At 2018-07-31 | 1,265,662 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 1,391,656 | USD | 92 |
| 2017-08-01 to 2017-10-31 | 554,575 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | -7,503,534 | USD | 92 |
| 2017-08-01 to 2017-10-31 | -5,927,188 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 30,625,847 | USD | |
| At 2018-07-31 | 28,621,823 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 5,657,376 | USD | |
| At 2018-07-31 | 5,849,636 | USD |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 59,674,487 | shares | |
| At 2018-07-31 | 53,511,626 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 91,876 | USD | |
| At 2018-07-31 | -16,024 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 25,197,721 | USD | |
| At 2018-07-31 | 22,924,206 | USD | |
| At 2017-10-31 | 13,539,142 | USD | |
| At 2017-07-31 | 10,695,982 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 1,995,176 | USD | |
| At 2018-07-31 | 1,995,176 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 790,385 | USD | |
| At 2018-07-31 | 729,514 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 346,470 | USD | |
| At 2018-07-31 | 358,987 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 1,322,011 | USD | |
| At 2018-07-31 | 1,472,630 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 1,487,579 | USD | |
| At 2018-07-31 | 1,070,744 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-10-31 | 2,150,966 | USD | |
| At 2018-07-31 | 1,643,749 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | -7,573,180 | USD | 92 |
| 2017-08-01 to 2017-10-31 | -5,900,452 | USD | 92 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | -7,467,715 | USD | 92 |
| 2017-08-01 to 2017-10-31 | -5,910,817 | USD | 92 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | -141,700,000 | USD | 92 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 2,764,089 | USD | 92 |
| 2017-08-01 to 2017-10-31 | 2,514,037 | USD | 92 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 60,871 | USD | 92 |
| 2017-08-01 to 2017-10-31 | 96,004 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2018-10-31 | 114,402 | USD | 92 |
| 2017-08-01 to 2017-10-31 | 26,736 | USD | 92 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))